NEWS
Childhood Measles Cases Jump 40 Percent After First Doses Slip
First-dose measles coverage fell to 81.0 percent by 2023 while second doses rose, and under-5 cases jumped 40 percent to 15.6 million.
Estimated measles cases among children under 5 rose 40 percent between 2019 and 2023, to 15.6 million, after first-dose coverage slipped even as second-dose coverage kept rising. A Global Burden of Disease analysis covering 204 countries and territories, published on 21 October 2026, also put under-5 measles deaths at 118,000 in 2023, up 12 percent from 2019.
Associate Professor Benn Sartorius of the University of Queensland’s Frazer Institute, who led the collaborator group with the Institute for Health Metrics and Evaluation at the University of Washington, said childhood measles immunization has been going backwards since COVID-19 and that the reversal has fed a resurgence in young children.
The First Dose Is the One That Slipped
The headline about falling measles vaccination hides a split inside the two-dose schedule. Global coverage with the first measles-containing dose, MCV1, rose from 67.2 percent in 1990 to 83.6 percent in 2019, then stalled and declined to 81.0 percent by 2023. Coverage with the second dose, MCV2, moved the other way: from 14.4 percent in 1990 to 68.4 percent in 2019, then on to 71.4 percent in 2023.
That 3.0-point rise in MCV2 is what a scale-up looks like. Countries that only recently added a second dose to routine schedules are still filling it in. The 2.6-point fall in MCV1 is the number that actually starts protection, and it is the one that went into reverse. An estimated 23.7 million infants, about 1 in 5, missed their first dose in 2023. A child who never receives MCV1 never becomes an MCV2 statistic.
Sartorius said two childhood doses are the most effective way to prevent measles and that vaccination was estimated to have prevented nearly 59 million deaths between 2000 and 2024. The World Health Organization uses the same nearly 59 million figure for that period. The GBD team’s point is narrower: the tool still works, and the first appointment is the one large systems are missing.
15.6 Million Under-5 Cases in 2023
Between 1990 and 2019, global measles incidence in this age group declined by about 80 percent and mortality by about 90 percent. The under-5 measles burden estimates then rebound after 2020. Cases in children under 5 went from 11.1 million in 2019 to 15.6 million in 2023. Deaths in that age group reached 118,000.
Those counts are modelled burden, not a tally of laboratory reports, which is why they sit above outbreak notices. They still line up with the coverage series: first-dose uptake peaked before the pandemic and then gave back 2.6 points, and cases in the youngest children jumped by 40 percent.
GLOBAL MEASLES VACCINE COVERAGE IN CHILDREN UNDER 5
| Dose | 1990 | 2019 | 2023 |
|---|---|---|---|
| First dose (MCV1) | 67.2% | 83.6% | 81.0% |
| Second dose (MCV2) | 14.4% | 68.4% | 71.4% |
Several regions remain well below the Immunization Agenda 2030 target of 90 percent coverage, the paper notes. That 90 percent bar is a programme goal. Stopping measles transmission is a higher bar, and health agencies set it at 95 percent with two doses. Global MCV2 at 71.4 percent in 2023 was not close to either line.
The Geography of 23.7 Million Missed First Doses
The missed first doses are not spread evenly, and neither is the death rate. Sartorius said sub-Saharan Africa recorded the highest measles mortality throughout the study period and accounted for 50 percent of the infants who missed MCV1 in 2023, with South Asia following at 20 percent. Together those two regions held 70 percent of the 23.7 million missed first doses.
WHERE THE MISSED FIRST DOSES SAT IN 2023
- The global miss: 23.7 million infants, about 1 in 5, did not receive MCV1.
- Sub-Saharan Africa: 50 percent of those missed first doses, and the highest under-5 measles death rate across 1990 to 2023.
- South Asia: 20 percent of missed first doses, the other large share of the remaining burden.
- High-income gaps: outbreaks have already returned where kindergarten coverage has fallen under 95 percent, including in the United States.
Sartorius said the greatest burden is in lower-resourced settings, yet recent outbreaks in the United States show measles can re-emerge in high-income countries where immunity gaps develop. The geography argument in the paper is not that rich countries are safe. It is that most of the children who never get dose one live in the two regions that already carry the deaths, and that a smaller immunity gap is enough to restart chains elsewhere.
Why Measles Punishes Small Coverage Gaps
Measles is an airborne virus, and the WHO estimates that one infected person can generate up to 18 secondary infections where immunity is low. That is why a 2.6-point fall in MCV1 is not a rounding error. The agency also says measles vaccination averted nearly 59 million deaths between 2000 and 2024, which is the long success the 2023 rebound is eating into.
The US Centers for Disease Control and Prevention says one measles dose is 93 percent effective and that two doses are 97 percent effective. CDC recommends the first MMR dose at 12 through 15 months and the second at 4 through 6 years, before school entry. WHO’s schedule starts earlier, at 9 months, in countries where measles is common. Either way, the second dose exists because the first dose leaves a minority unprotected, and because measles will find that minority if enough children miss the first visit.
Measles outbreaks are the canary in the coal mine, exposing and exploiting gaps in immunization and hitting the most vulnerable first.
Dr Tedros Adhanom Ghebreyesus, WHO Director-General, on 2023 immunization estimates
Tedros made that canary in the coal mine remark when WHO and UNICEF released 2023 coverage figures, before this GBD paper quantified the under-5 case rebound. The 2023 analysis is the burden version of the same warning: measles is the first routine vaccine to announce that catch-up has not finished, because it needs more population immunity than almost any other childhood shot.
96 Percent Second-Dose Coverage in Australasia
The same dataset has a control group. Despite COVID-19 disruptions, Australasia kept some of the highest measles vaccination coverage in the world. Between 1990 and 2019 the region recorded one of the largest increases in second-dose coverage, and by 2023 it had the highest coverage of any region, with an estimated 96 percent of children under 5 receiving a second dose.
That figure sits above the 95 percent transmission line and well above the 71.4 percent global MCV2 average. It is also the cleanest evidence in the paper that the post-2020 rebound was not automatic. Health systems that held the second-year-of-life visit, and that kept first-dose access from collapsing, did not hand measles the same opening.
Sartorius said the maps should help authorities find under-vaccinated populations before the next outbreak, and that he hopes the data will be used to target catch-up and to strengthen immunization where support is needed most. Australasia is the picture of what that target looks like when it is met.
Kindergarten MMR in the United States Is Below the 95 Percent Line
The United States is the high-income example the paper flags, and school-entry data make the gap concrete. For the 2023-24 school year, CDC reported 92.7 percent kindergarten MMR coverage with two doses, down from about 95 percent across required vaccines in 2019-20. That 92.7 percent national average is already under the 95 percent herd line.
US KINDERGARTEN MMR, 2023-24 SCHOOL YEAR
- National two-dose MMR: 92.7 percent of kindergartners.
- The range: 79.6 percent in Idaho to 98.3 percent in West Virginia.
- Above the herd line: 11 jurisdictions at or above 95 percent.
- Well below it: 14 jurisdictions under 90 percent, with exemptions at 3.3 percent nationally.
MMR coverage fell in 35 jurisdictions compared with 2022-23. Sartorius said misinformation has risen in pockets of populations after COVID-19, and that the United States has not helped with this narrative. School-entry rules have not closed every gap, and Florida measles risk past the school mandate is one state-level version of the same arithmetic: a few points under 95 percent is enough for measles to travel when someone brings it in.
What Happens When Coverage Falls Below 95 Percent
Bangladesh had been near that line. WHO and UNICEF estimated 96 percent MCV1 and 93 percent MCV2 there in 2024. In 2025 those figures fell to 90 percent and 86 percent. From mid-March 2026 through 9 October 2026, WHO figures put suspected measles cases at 202,000, including 22,000 laboratory-confirmed infections, and 1,147 deaths, with 94 percent of the reported deaths in children under 5.
That outbreak is outside the GBD window, which ends in 2023, and it is the live version of the paper’s warning. A country that had been a coverage success lost a handful of points on the first dose, then logged more suspected measles than any other country in 2026. Catch-up campaigns can still post high numbers while leaving pockets of children who were never on the list.
FROM A 30-YEAR DECLINE TO A 2026 OUTBREAK
- 1990 to 2019: Global under-5 measles incidence falls by about 80 percent and mortality by about 90 percent, while MCV1 climbs to 83.6 percent and MCV2 to 68.4 percent.
- 2020: COVID-19 disrupts routine immunization, health systems, and funding, the GBD authors say, and measles control proves fragile.
- 2023: Estimated under-5 cases reach 15.6 million and deaths 118,000; 23.7 million infants miss MCV1; global MCV1 sits at 81.0 percent and MCV2 at 71.4 percent.
- 2023-24 school year: US kindergarten two-dose MMR coverage is 92.7 percent, with 14 jurisdictions under 90 percent.
- 2025: Bangladesh first-dose coverage is estimated at 90 percent and second-dose at 86 percent, down from 96 percent and 93 percent in 2024.
- 21 October 2026: The GBD 2023 measles paper is published, mapping the 1990-to-2023 reversal.
- Mid-March to 9 October 2026: WHO figures for Bangladesh reach 202,000 suspected cases and 1,147 deaths, 94 percent of them in children under 5.
Sartorius said urgent action is needed to restore routine immunization programmes and to build health systems that can hold high coverage through a global crisis. The 2023 estimates show where that work starts: the first dose, in the regions that already hold most of the misses, before another coverage slip writes another outbreak into the next GBD round.
Frequently Asked Questions
How many measles vaccine doses do children need?
Children need two doses. CDC schedules the first MMR dose at 12 through 15 months and the second at 4 through 6 years, and allows the second dose as soon as 28 days after the first. WHO recommends the first dose at 9 months of age in countries where measles is common, with a later second dose, usually at 15 to 18 months, because infants in those settings face earlier exposure.
Why does measles control require 95 percent coverage?
Measles virus can stay infectious in the air or on surfaces for up to two hours, and about 90 percent of people without immunity who meet a case become infected. At an R0 often cited between 12 and 18, health agencies use 95 percent two-dose coverage so that even imperfect vaccine effectiveness and uneven neighbourhood uptake still leave too few susceptible contacts for chains to run.
What is the difference between MCV1 and MCV2 coverage?
MCV1 is the share of children who receive the first measles-containing dose; MCV2 is the share who receive the second. MCV2 can keep rising when more countries introduce a second dose, even while MCV1 falls because infants miss the first visit. Immunization Agenda 2030 sets a 90 percent coverage target; measles elimination still depends on 95 percent with both doses.
How deadly is measles for infants in poorer countries?
In hospital-based settings across low- and middle-income countries, a 2023 modelling study led by Alyssa N. Sbarra estimated a mean 2019 case-fatality ratio of 5.35 percent for people aged 0 to 34 years, much higher than the 1.32 percent mean in community-based settings for the same ages, because hospitals see sicker patients. Malnutrition and a weak immune system raise the risk of death further.
Did the measles vaccine stop saving lives after COVID-19?
No. WHO says measles vaccination averted nearly 59 million deaths between 2000 and 2024, and that about 29 million infants remained under-protected against measles in 2025. The GBD 2023 paper measures a rebound in under-5 cases and deaths through 2023, not a failure of the vaccine in children who actually receive both doses.
Disclaimer: This article is news reporting and analysis of a published epidemiology study and official immunization figures, and it is for information only. It is not medical advice, a vaccination recommendation, or a diagnosis, and it does not tell any parent or clinician what to do in an individual case. Readers should consult a qualified physician or paediatrician, and follow their national immunization schedule, before making decisions about measles vaccination or outbreak response. Case counts, coverage rates, and outbreak tallies reflect the studies and health-agency figures cited here and can change as estimates are revised.
-
NEWS3 months agoGeneration Lab’s Secret Youth Shot Has a Copycat Problem
-
AUTO3 months agoTesla Raises Dual Motor Prices as Texas Builds Cybercabs
-
LIFESTYLE3 months agoThe Nantucket Friendship Basket Boom Meets a Maker Shortage
-
NEWS3 months agoOkta Stock Jumps 20% on McKinnon’s Identity Bet
-
BUSINESS3 months agoBristol Myers Quits Cellares as Autoimmune Doses Proceed
-
BUSINESS3 months agoPoland Closes Visa-Free Work for Three Fast-Growing Nationalities
-
LIFESTYLE3 months agoLabor Day Mattress Sales Repeat a Familiar Holiday Discount
-
NEWS3 months agoGoogle Ends EU Spam Demotions but Keeps the Ranking Split
